期刊文献+

心脏病妊娠风险分级在妊娠合并心脏病中的临床应用及预测价值分析 被引量:6

The Clinical Application and Predictive Value of Risk Classificaiton System in Pregnancies Complicated with Cardiac Disease
下载PDF
导出
摘要 目的:探讨中华医学会的心脏病不同妊娠风险分级母儿并发症情况及其与CARPREGⅡ风险评分法对妊娠期心血管并发症的预测价值分析。方法:对2016年1月1日至2018年12月31日339例妊娠合并心脏病的孕产妇进行妊娠风险分级,分析患者心血管并发症、产科并发症及胎儿并发症与妊娠风险分级间的关系,并对其与CARPREGⅡ风险评分对心血管并发症的预测价值使用ROC曲线进行分析。结果:①妊娠风险分级Ⅰ级130例(38.3%),Ⅱ级73例(21.5%),Ⅲ级51例(15.0%),Ⅳ级45例(13.3%),Ⅴ级40例(11.8%)。妊娠风险分级越高,纽约心脏病协会(NYHA)心功能分级Ⅲ~Ⅳ级所占比例越高(χ^2=190.271,P<0.001)。②妊娠合并心脏病妇女心血管并发症发生率为13.0%,产科并发症和胎儿并发症的发生率分别为13.9%和24.5%。不同妊娠分级的心血管并发症(心功能衰竭、呼吸衰竭、血栓/栓塞、死亡)和胎儿并发症(孕早中期流产、围产儿死亡、早产、胎儿生长受限)发生率及产科并发症中妊娠期高血压疾病的发生率比较,差异均有统计学意义(P<0.05),且妊娠风险分级越高,其胎儿并发症、心血管并发症及妊娠期高血压疾病的发生率有增加的趋势。③ROC曲线分析发现,妊娠风险分级预测心血管并发症的曲线下面积(AUC)为0.866(95%CI 0.802~0.930),CARPREGⅡ评分法的AUC为0.808(95%CI 0.722~0.894)。结论:中华医学会的心脏病妊娠风险分级方法简单,利于对妊娠合并心脏病孕妇的分层及个体化管理,对于妊娠期心血管并发症有良好的预测价值。 Objective:To describe the maternal and neonatal complications in pregnancy with heart disease and compare the predictive value of Chinese Medical Association risk classification system and CARPREGⅡscoring system.Methods:The pregnancy risks of 339 pregnant women with heart disease were evaluated from 1st Jan 2016 to 31st Dec 2018.The relationship between pregnancy risk classification and cardiovascular complications,obstetric complications and fetal complications was analyzed.ROC curve was used for comparison of Chinese Medical Association risk classification system and CARPREGⅡscoring system in prediction of cardiovascular complications.Results:①130 women were included in risk categoryⅠ(38.3%),73 women in categoryⅡ(21.5%),51 women in categoryⅢ(15.0%),45 women in categoryⅣ(13.3%),and 40 women in categoryⅤ(11.8%).The proportion of women with NYHA heart function gradeⅢ-Ⅳwas increased with higher pregnancy risk category(χ^2=190.271,P<0.001).②The incidence of cardiovascular complications,obstetric complications and perinatal complicationswas 13.0%,13.9%and 24.5%respectively.There were significant differences in the incidence of cardiovascular complications(heart failure,respiratory failure,thrombus/embolism,death),fetal complications(abortion in the first and second trimester,perinatal death,preterm delivery,fetal growth restriction)and pregnancy induced hypertension between different risk categories(P<0.05).③ROC curve analysis showed the AUC was 0.866(95%CI 0.802-0.930)for Chinese Medical Association risk classification system and 0.808(95%CI 0.722-0.894)for CARPREGⅡscoring system.Conclusions:The Chinese Medical Association risk classification system is simple.It is easy to perform the classification and individual administration of pregnant women complicated with heart disease.The system has been shown with good predictive value for cardiac complications in pregnancy.
作者 顾宁 严燏雯 王志群 戴毅敏 GU Ning;YAN Yuwen;WANG Zhiqun(Department of Obstetrics and Gynecology,Nanjing Drum Tower Hospital,Nanjing University Medical School,Nanjing Jiangsu 210008,China)
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2020年第10期757-762,共6页 Journal of Practical Obstetrics and Gynecology
关键词 妊娠 心脏病 妊娠风险分级 CARPREGⅡ风险评分 Pregnancy Heart disease Risk classification in pregnancy CARPREGⅡ
  • 相关文献

参考文献2

二级参考文献27

  • 1无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3693
  • 2Evangelista A, Avegliano G, Aguilar R, et al. Impact of contrast-enhanced echocardiography on the diagnostic algorithm of acute aortic dissection[J]. Eur Heart J, 2010,31(4): 472-479.
  • 3ACOG Committee on Obstetric Praetiee. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy[J]. Obstet Gynecol, 2004, 1 04(3):647-651.
  • 4Kampman MA, Balei A, van Veldhuisen DJ, et al. N-terminal pro-B-type natriuretie peptide predicts cardiovascular complications in pregnant women with congenital heart disease [J]. Eur Heart J, 2014,35(11):708-715.
  • 5European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) [J]. Eur Heart J. 2011,32(24):3147-3197.
  • 6Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease[J]. Circulation, 2001,104(5):515-521.
  • 7Drenthen W, Boersma E, Balei A, et al. Predictors of pregnancy complications in women with congenital heart disease[J]. Eur Heart J, 2010,31(17):2124-2132.
  • 8Hurst JW. The value of using the entire New York Heart Association' s classificationof heart and vascular disease[J]. Clin C ardiol, 2006, 29(9):415-417.
  • 9Mukoyama M, Nakao K, Hosodo K, et al. Brain natriureticpeptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide[J]. J Clin Invest, 1991, 87(4):1402-1412.
  • 10Kim SW, Park SW, Lira SH, et al. Amount of left ventrieular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction [J]. Clin Cardiol, 2006,29(4):155-160.

共引文献4881

同被引文献92

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部